Axumin
Payments companies reported to CMS as associated with Axumin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Axumin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Axumin
These are the largest totals companies reported as associated with Axumin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Sampson | Aurora, CO | Neurological Surgery | $44,972.50 |
| Priya Kumthekar | Chicago, IL | Hematology & Oncology | $38,070.00 |
| Christopher Spencer | Rolla, MO | Radiation Oncology | $37,250.00 |
| Bret Mobley | Nashville, TN | Anatomic Pathology | $33,800.00 |
| Joshua Lantos | New York, NY | Neuroradiology | $28,760.00 |
| Matthew Kay | Tucson, AZ | Diagnostic Radiology | $16,000.00 |
| Ephraim Parent | Jacksonville, FL | Nuclear Medicine | $16,000.00 |
| Alexandru Bageac | Fort Worth, TX | Diagnostic Radiology | $15,701.90 |
| Whitney Pope | Los Angeles, CA | Diagnostic Radiology | $13,800.00 |
| Seyed Nabavizadeh | Philadelphia, PA | Diagnostic Radiology | $7,700.00 |
Prescribed Axumin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.